{"id":59943,"date":"2024-02-28T06:25:03","date_gmt":"2024-02-28T06:25:03","guid":{"rendered":"https:\/\/medsname.com\/lonax\/"},"modified":"2026-05-01T10:49:15","modified_gmt":"2026-05-01T10:49:15","slug":"lonax","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/lonax\/","title":{"rendered":"Lonax"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 Rychl\u00e1 odpov\u011b\u010f \u2014 Co je Lonax?<\/h3>\n<p style=\"margin:0;\"><strong>Lonax<\/strong> je peror\u00e1ln\u00ed <strong>oxkarbazepin<\/strong> (150 mg, 300 mg) antikonvulzivum \u2014 ketoanalog karbamazepinu se srovnatelnou \u00fa\u010dinnost\u00ed, jednodu\u0161\u0161\u00ed farmakokinetikou a m\u00e9n\u011b l\u00e9kov\u00fdmi interakcemi. Pou\u017e\u00edv\u00e1 se k l\u00e9\u010db\u011b: <strong>parci\u00e1ln\u00edch z\u00e1chvat\u016f s nebo bez sekund\u00e1rn\u00ed generalizace<\/strong> jako monoterapie nebo dopl\u0148kov\u00e1 l\u00e9\u010dba u dosp\u011bl\u00fdch a d\u011bt\u00ed &gt;2 let. D\u00e1vkov\u00e1n\u00ed u dosp\u011bl\u00fdch: za\u010dn\u011bte 300 mg 2\u00d7 denn\u011b, titrujte t\u00fddn\u011b o 600 mg\/den na udr\u017eovac\u00ed d\u00e1vku <strong>1 200\u20132 400 mg\/den<\/strong> ve 2 rozd\u011blen\u00fdch d\u00e1vk\u00e1ch. U\u017e\u00edvejte s j\u00eddlem nebo bez. N\u00e1stup \u00fa\u010dinku na kontrolu z\u00e1chvat\u016f: obvykle do 2\u20133 t\u00fddn\u016f od titrace. \u010cast\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky: z\u00e1vrat\u011b, ospalost, dvojit\u00e9 vid\u011bn\u00ed, bolest hlavy, hyponatr\u00e9mie. <strong>Sledujte hladinu sod\u00edku<\/strong> \u2014 klinicky v\u00fdznamn\u00e1 hyponatr\u00e9mie u 2\u20133 % dosp\u011bl\u00fdch, \u010dast\u011bji u star\u0161\u00edch pacient\u016f. Zk\u0159\u00ed\u017een\u00e1 reaktivita s karbamazepinem u ~25\u201330 % pacient\u016f s p\u0159edchoz\u00ed vyr\u00e1\u017ekou z karbamazepinu. Nikdy nep\u0159eru\u0161ujte n\u00e1hle \u2014 riziko rebound z\u00e1chvat\u016f.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdrobce certifikovan\u00fd WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 doprava \u00b7 V\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a jsou expedov\u00e1ny po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2013 na vn\u011bj\u0161\u00ed stran\u011b bal\u00edku nen\u00ed uveden n\u00e1zev l\u00e9ku. Platby kartou jsou sm\u011brov\u00e1ny prost\u0159ednictv\u00edm regulovan\u00e9ho procesoru (popisky na v\u00fdpisu zahrnuj\u00ed regulovan\u00e9ho procesora plateb kartou \u2013 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed politikou p\u0159eposl\u00e1n\u00ed.<\/p>\n<h2 class=\"wp-block-heading\">Co je Lonax?<\/h2>\n<p>Lonax jsou tablety oxkarbazepinu pro peror\u00e1ln\u00ed pod\u00e1n\u00ed dostupn\u00e9 v sil\u00e1ch 150 mg a 300 mg. Oxkarbazepin je 10-keto analog karbamazepinu vyvinut\u00fd v 90. letech 20. stolet\u00ed, kter\u00fd zachov\u00e1v\u00e1 \u00fa\u010dinnost karbamazepinu, ale eliminuje aktivn\u00ed metabolit (karbamazepin-10,11-epoxid) zodpov\u011bdn\u00fd za mnoho ne\u017e\u00e1douc\u00edch \u00fa\u010dink\u016f a l\u00e9kov\u00fdch interakc\u00ed karbamazepinu. V\u00fdsledkem je chemicky p\u0159\u00edbuzn\u00fd l\u00e9k s v\u00fdrazn\u011b lep\u0161\u00ed sn\u00e1\u0161enlivost\u00ed a mnohem jednodu\u0161\u0161\u00edm profilem interakc\u00ed.<\/p>\n<p>Lonax je dod\u00e1v\u00e1n v\u00fdrobcem certifikovan\u00fdm WHO-GMP a je bioekvivalentn\u00ed s origin\u00e1ln\u00edm oxkarbazepinem (Trileptal\u00ae, Novartis).<\/p>\n<h2 class=\"wp-block-heading\">Jak Lonax funguje?<\/h2>\n<p>Oxkarbazepin je prol\u00e9\u010divo, kter\u00e9 se rychle redukuje na sv\u016fj aktivn\u00ed metabolit <strong>10-monohydroxy-deriv\u00e1t (MHD, eslikarbazepin)<\/strong>:<\/p>\n<ul>\n<li><strong>Blok\u00e1da nap\u011b\u0165ov\u011b \u0159\u00edzen\u00fdch sod\u00edkov\u00fdch kan\u00e1l\u016f<\/strong> v z\u00e1vislosti na pou\u017eit\u00ed \u2014 prim\u00e1rn\u00ed antikonvulzivn\u00ed mechanismus. Preferen\u010dn\u011b utlumuje hyperaktivn\u00ed neurony.<\/li>\n<li><strong>Modulace vysokonap\u011b\u0165ov\u011b aktivovan\u00fdch kalciov\u00fdch kan\u00e1l\u016f<\/strong> \u2014 sni\u017euje excita\u010dn\u00ed p\u0159enos.<\/li>\n<li><strong>Zv\u00fd\u0161en\u00e1 vodivost drasl\u00edku<\/strong> \u2014 d\u00e1le sni\u017euje dr\u00e1\u017edivost.<\/li>\n<\/ul>\n<p>Na rozd\u00edl od karbamazepinu oxkarbazepin <strong>siln\u011b neindukuje CYP3A4<\/strong>, tak\u017ee m\u00e1 m\u00e9n\u011b interakc\u00ed s jin\u00fdmi l\u00e9ky (statiny, antikoagulancia, or\u00e1ln\u00ed antikoncepce jsou m\u00e9n\u011b ovlivn\u011bny, i kdy\u017e vysok\u00e9 d\u00e1vky st\u00e1le sni\u017euj\u00ed antikoncep\u010dn\u00ed \u00fa\u010dinnost). Neindukuje sv\u016fj vlastn\u00ed metabolismus, co\u017e znamen\u00e1, \u017ee zv\u00fd\u0161en\u00ed d\u00e1vek vede k p\u0159edv\u00eddateln\u00fdm zm\u011bn\u00e1m hladin \u2014 klinicky jednodu\u0161\u0161\u00ed ne\u017e karbamazepin.<\/p>\n<h2 class=\"wp-block-heading\">Pou\u017eit\u00ed a indikace<\/h2>\n<ul>\n<li><strong>Parci\u00e1ln\u00ed (fok\u00e1ln\u00ed) z\u00e1chvaty<\/strong> s nebo bez sekund\u00e1rn\u00ed generalizace \u2014 monoterapie a adjuvantn\u00ed l\u00e9\u010dba (schv\u00e1leno FDA u dosp\u011bl\u00fdch a d\u011bt\u00ed &gt;2 let)<\/li>\n<li><strong>Mimo indikaci:<\/strong> trigemin\u00e1ln\u00ed neuralgie (alternativa k karbamazepinu, \u010dasto l\u00e9pe sn\u00e1\u0161en), udr\u017eovac\u00ed l\u00e9\u010dba bipol\u00e1rn\u00ed poruchy (p\u0159ev\u00e1\u017en\u011b historick\u00e9, nikoli prvn\u00ed volba), neuropatick\u00e1 bolest<\/li>\n<\/ul>\n<p>Lonax je <strong>ne<\/strong> prvn\u00ed volba u: generalizovan\u00fdch tonicko-klonick\u00fdch z\u00e1chvat\u016f (pou\u017eijte lamotrigin nebo valpro\u00e1t), absenc\u00ed nebo myoklonick\u00fdch z\u00e1chvat\u016f (m\u016f\u017ee je zhor\u0161it \u2014 t\u0159\u00eddn\u00ed \u00fa\u010dinek blok\u00e1tor\u016f sod\u00edkov\u00fdch kan\u00e1l\u016f u genetick\u00e9 generalizovan\u00e9 epilepsie) nebo akutn\u00ed m\u00e1nie.<\/p>\n<h2 class=\"wp-block-heading\">D\u00e1vkov\u00e1n\u00ed Lonaxu a zp\u016fsob u\u017e\u00edv\u00e1n\u00ed<\/h2>\n<p>S\u00edly Lonaxu: <strong>150 mg, 300 mg<\/strong>.<\/p>\n<p><strong>Standardn\u00ed d\u00e1vkov\u00e1n\u00ed pro dosp\u011bl\u00e9:<\/strong><\/p>\n<ul>\n<li><strong>Monoterapie:<\/strong> Za\u010dn\u011bte 300 mg dvakr\u00e1t denn\u011b. Zvy\u0161ujte o 300 mg\/den ka\u017ed\u00e9 3 dny podle tolerance. Udr\u017eovac\u00ed d\u00e1vka 1 200\u20132 400 mg\/den ve 2 d\u00e1vk\u00e1ch.<\/li>\n<li><strong>Adjuvantn\u00ed terapie:<\/strong> Za\u010dn\u011bte 300 mg dvakr\u00e1t denn\u011b; titrujte t\u00fddn\u011b o 600 mg\/den. Udr\u017eovac\u00ed d\u00e1vka 1 200 mg\/den (n\u011bkte\u0159\u00ed pacienti pot\u0159ebuj\u00ed a\u017e 2 400 mg\/den).<\/li>\n<li><strong>D\u011bti 2\u201316 let:<\/strong> Za\u010dn\u011bte 8\u201310 mg\/kg\/den ve 2 d\u00e1vk\u00e1ch, zvy\u0161ujte t\u00fddn\u011b na 30\u201346 mg\/kg\/den podle hmotnosti.<\/li>\n<li><strong>P\u0159echod z karbamazepinu:<\/strong> pou\u017eijte 1,5\u00d7 celkovou denn\u00ed d\u00e1vku karbamazepinu; titrujte po dobu 2 t\u00fddn\u016f p\u0159i postupn\u00e9m sni\u017eov\u00e1n\u00ed d\u00e1vky karbamazepinu.<\/li>\n<li><strong>Porucha funkce ledvin<\/strong> (CrCl &lt;30 ml\/min): polovi\u010dn\u00ed po\u010d\u00e1te\u010dn\u00ed d\u00e1vka, pomalej\u0161\u00ed titrace.<\/li>\n<\/ul>\n<h3 class=\"wp-block-heading\">Jak spr\u00e1vn\u011b u\u017e\u00edvat Lonax<\/h3>\n<ol>\n<li><strong>Dvakr\u00e1t denn\u011b, v pravideln\u00fdch intervalech.<\/strong> Aktivn\u00ed metabolit MHD m\u00e1 polo\u010das 9 hodin; d\u00e1vkov\u00e1n\u00ed dvakr\u00e1t denn\u011b udr\u017euje stabiln\u00ed hladiny.<\/li>\n<li><strong>S j\u00eddlem nebo bez j\u00eddla.<\/strong> Potrava v\u00fdznamn\u011b neovliv\u0148uje vst\u0159eb\u00e1v\u00e1n\u00ed; mnoho pacient\u016f ji u\u017e\u00edv\u00e1 s j\u00eddlem, aby sn\u00ed\u017eili nevolnost.<\/li>\n<li><strong>Z\u00e1kladn\u00ed kontrola sod\u00edku, pot\u00e9 za 2 t\u00fddny a \u010dtvrtletn\u011b.<\/strong> Hyponatr\u00e9mie je nejv\u00fdrazn\u011bj\u0161\u00edm vedlej\u0161\u00edm \u00fa\u010dinkem \u2014 klinicky v\u00fdznamn\u00e1 u 2\u20133 % dosp\u011bl\u00fdch, \u010dast\u011bji u star\u0161\u00edch osob a p\u0159i u\u017e\u00edv\u00e1n\u00ed diuretik.<\/li>\n<li><strong>Informujte ka\u017ed\u00e9ho p\u0159edepisuj\u00edc\u00edho l\u00e9ka\u0159e.<\/strong> Oxkarbazepin m\u00e1 m\u00e9n\u011b interakc\u00ed ne\u017e karbamazepin, ale st\u00e1le ovliv\u0148uje \u00fa\u010dinnost hormon\u00e1ln\u00ed antikoncepce p\u0159i d\u00e1vk\u00e1ch nad 1 200 mg\/den.<\/li>\n<li><strong>Umo\u017en\u011bte 2\u20133 t\u00fddny v terapeutick\u00e9 d\u00e1vce<\/strong> p\u0159ed posouzen\u00edm \u00fa\u010dinku na z\u00e1chvaty.<\/li>\n<li><strong>P\u0159i jak\u00e9koli nov\u00e9 vyr\u00e1\u017ece l\u00e9\u010dbu p\u0159eru\u0161te<\/strong> v prvn\u00edch 8 t\u00fddnech. Riziko SJS\/TEN je v\u00fdrazn\u011b zv\u00fd\u0161eno u pacient\u016f s HLA-B*1502 (populace Han \u010c\u00ed\u0148an\u016f, Thajc\u016f, Indon\u00e9san\u016f) \u2014 p\u0159ed l\u00e9\u010dbou se doporu\u010duje testov\u00e1n\u00ed na HLA-B*1502 u t\u011bchto populac\u00ed.<\/li>\n<li><strong>Nikdy nep\u0159est\u00e1vejte n\u00e1hle.<\/strong> Mo\u017en\u00e9 jsou rebound z\u00e1chvaty v\u010detn\u011b status epilepticus. Sni\u017eujte d\u00e1vku postupn\u011b po dobu 2\u20134 t\u00fddn\u016f pod l\u00e9ka\u0159sk\u00fdm dohledem.<\/li>\n<li><strong>\u0158\u00edzen\u00ed vozidla:<\/strong> vyhn\u011bte se a\u017e do stabilizace d\u00e1vky \u2014 z\u00e1vrat\u011b a dvojit\u00e9 vid\u011bn\u00ed jsou b\u011b\u017en\u00e9 b\u011bhem titra\u010dn\u00ed f\u00e1ze.<\/li>\n<\/ol>\n<h2 class=\"wp-block-heading\">Vedlej\u0161\u00ed \u00fa\u010dinky Lonaxu<\/h2>\n<p><strong>\u010cast\u00e9 (\u010dasto z\u00e1visl\u00e9 na d\u00e1vce, mohou ustoupit p\u0159i pomalej\u0161\u00ed titraci):<\/strong><\/p>\n<ul>\n<li>Z\u00e1vrat\u011b, nestabilita<\/li>\n<li>Ospalost, \u00fanava<\/li>\n<li>Diplopie (dvojit\u00e9 vid\u011bn\u00ed), nystagmus<\/li>\n<li>Bolest hlavy<\/li>\n<li>Nevolnost, zvracen\u00ed<\/li>\n<li>Tremor, ataxie \u2014 obvykle p\u0159i rychl\u00e9 titraci<\/li>\n<li>M\u00edrn\u00e1 vyr\u00e1\u017eka (5\u201310 %)<\/li>\n<\/ul>\n<p><strong>M\u00e9n\u011b \u010dast\u00e9, ale d\u016fle\u017eit\u00e9:<\/strong><\/p>\n<ul>\n<li><strong>Hyponatr\u00e9mie<\/strong> \u2014 s\u00e9rov\u00fd sod\u00edk 65 let, sou\u010dasn\u00e9 u\u017e\u00edv\u00e1n\u00ed diuretik, srde\u010dn\u00ed selh\u00e1n\u00ed, SSRI.<\/li>\n<li>Zpomalen\u00ed kognitivn\u00edch funkc\u00ed<\/li>\n<li>Porucha n\u00e1lady<\/li>\n<li>Akn\u00e9<\/li>\n<li>Zv\u00fd\u0161en\u00e9 jatern\u00ed enzymy (vz\u00e1cn\u00e9)<\/li>\n<li>Sn\u00ed\u017een\u00fd po\u010det krevn\u00edch desti\u010dek (vz\u00e1cn\u00e9)<\/li>\n<\/ul>\n<p><strong>Vz\u00e1cn\u00e9, ale vy\u017eaduje neodkladnou p\u00e9\u010di:<\/strong><\/p>\n<ul>\n<li><strong>Stevens-Johnson\u016fv syndrom \/ TEN<\/strong> \u2014 zejm\u00e9na u nositel\u016f HLA-B*1502 (\u010d\u00ednsk\u00e1, thajsk\u00e1, indon\u00e9sk\u00e1 populace). FDA doporu\u010duje testov\u00e1n\u00ed HLA-B*1502 p\u0159ed zah\u00e1jen\u00edm l\u00e9\u010dby u t\u011bchto populac\u00ed.<\/li>\n<li><strong>DRESS syndrom<\/strong> \u2014 hore\u010dka, vyr\u00e1\u017eka, eozinofilie, hepatitida. Okam\u017eit\u011b ukon\u010dit l\u00e9\u010dbu.<\/li>\n<li><strong>T\u011b\u017ek\u00e1 hyponatr\u00e9mie<\/strong> p\u0159i z\u00e1chvatech, encefalopatii<\/li>\n<li>Anafylaxe<\/li>\n<li>Sebevra\u017eedn\u00e9 my\u0161lenky \u2014 varov\u00e1n\u00ed pro celou t\u0159\u00eddu l\u00e9k\u016f<\/li>\n<li>\u00datlum kostn\u00ed d\u0159en\u011b (velmi vz\u00e1cn\u00e9)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Varov\u00e1n\u00ed a opat\u0159en\u00ed<\/h2>\n<ul>\n<li><strong>Hyponatr\u00e9mie<\/strong> \u2014 nejv\u00fdrazn\u011bj\u0161\u00ed vedlej\u0161\u00ed \u00fa\u010dinek. Kontrolovat sod\u00edk na za\u010d\u00e1tku, po 2 t\u00fddnech, pot\u00e9 \u010dtvrtletn\u011b. P\u0159eru\u0161it nebo sn\u00ed\u017eit d\u00e1vku p\u0159i p\u0159\u00edznac\u00edch nebo pokud sod\u00edk &lt;125 mmol\/l.<\/li>\n<li><strong>Zk\u0159\u00ed\u017een\u00e1 reaktivita s karbamazepinem<\/strong> \u2014 U ~25\u201330 % pacient\u016f, kte\u0159\u00ed m\u011bli vyr\u00e1\u017eku p\u0159i u\u017e\u00edv\u00e1n\u00ed karbamazepinu, se m\u016f\u017ee objevit vyr\u00e1\u017eka i p\u0159i u\u017e\u00edv\u00e1n\u00ed oxkarbazepinu. Z\u00e1va\u017en\u00e9 reakce na karbamazepin (SJS\/DRESS) jsou kontraindikac\u00ed pro oxkarbazepin.<\/li>\n<li><strong>HLA-B*1502 u populace Han \u010c\u00ed\u0148an\u016f, Thajc\u016f a Indon\u00e9san\u016f<\/strong> \u2014 v\u00fdrazn\u011b zv\u00fd\u0161en\u00e9 riziko SJS\/TEN. FDA doporu\u010duje genotypizaci p\u0159ed zah\u00e1jen\u00edm l\u00e9\u010dby.<\/li>\n<li><strong>Kombinovan\u00e9 peror\u00e1ln\u00ed antikoncepce<\/strong> \u2014 d\u00e1vky &gt;1 200 mg\/den mohou sn\u00ed\u017eit \u00fa\u010dinnost antikoncepce. P\u0159i t\u00e9to d\u00e1vce pou\u017eijte z\u00e1lo\u017en\u00ed antikoncepci nebo pilulku s vy\u0161\u0161\u00edm obsahem estrogenu.<\/li>\n<li><strong>T\u011bhotenstv\u00ed<\/strong> \u2014 klasifikace D; sni\u017euje hladinu fol\u00e1tu, m\u00edrn\u011b zvy\u0161uje riziko malformac\u00ed oproti popula\u010dn\u00edmu pr\u016fm\u011bru. Fol\u00e1t 5 mg\/den; dohled specialisty.<\/li>\n<li><strong>Star\u0161\u00ed dosp\u011bl\u00ed a pacienti u\u017e\u00edvaj\u00edc\u00ed diuretika<\/strong> \u2014 v\u00fdrazn\u011b zv\u00fd\u0161en\u00e9 riziko hyponatr\u00e9mie. \u010cast\u011bji kontrolujte hladinu sod\u00edku.<\/li>\n<li><strong>Sebevra\u017eedn\u00e9 my\u0161lenky<\/strong> \u2014 t\u0159\u00eddn\u00ed varov\u00e1n\u00ed pro v\u0161echna antikonvulziva.<\/li>\n<li><strong>Nikdy nevysazujte n\u00e1hle<\/strong> \u2014 rebound z\u00e1chvaty.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kontraindikace \u2014 Kdo by NEM\u011aL u\u017e\u00edvat Lonax<\/h2>\n<ul>\n<li>Zn\u00e1m\u00e1 p\u0159ecitliv\u011blost na oxkarbazepin, karbamazepin, eslikarbazepin nebo jakoukoli pomocnou l\u00e1tku tablety.<\/li>\n<li>Historie t\u011b\u017ek\u00e9 vyr\u00e1\u017eky, SJS\/TEN nebo DRESS po karbamazepinu nebo oxkarbazepinu<\/li>\n<li>T\u011b\u017ek\u00e1 hyponatr\u00e9mie v\u00fdchoz\u00ed (relativn\u00ed)<\/li>\n<li>Atrioventrikul\u00e1rn\u00ed blok (relativn\u00ed; blok\u00e1tory sod\u00edkov\u00fdch kan\u00e1l\u016f mohou zhor\u0161it)<\/li>\n<li>D\u011bti &lt;2 roky (\u00fa\u010dinnost\/bezpe\u010dnost nebyla stanovena)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interakce s l\u00e9\u010divy<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Kombinujte s<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">\u00da\u010dinek<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Co d\u011blat<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Kombinovan\u00e9 peror\u00e1ln\u00ed antikoncepce (estrogen + progestogen)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Oxkarbazepin &gt;1 200 mg\/den sni\u017euje hladiny estrogenu a progestogenu<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Pou\u017eijte pilulku s vy\u0161\u0161\u00edm obsahem estrogenu, alternativn\u00ed antikoncepci nebo bari\u00e9rovou z\u00e1lohu p\u0159i vysok\u00fdch d\u00e1vk\u00e1ch.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Fenytoin<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Oxkarbazepin zvy\u0161uje hladiny fenytoinu (~40 %)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitorujte hladinu fenytoinu; m\u016f\u017ee b\u00fdt nutn\u00e1 \u00faprava d\u00e1vky.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Karbamazepin, fenobarbital, fenytoin<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Sni\u017ete hladiny MHD oxkarbazepinu<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Mohou b\u00fdt pot\u0159eba vy\u0161\u0161\u00ed d\u00e1vky oxkarbazepinu.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Lamotrigin<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">M\u00edrn\u00e9 sn\u00ed\u017een\u00ed hladin lamotriginu<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">M\u016f\u017ee b\u00fdt nutn\u00e1 m\u00edrn\u00e1 \u00faprava d\u00e1vky.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Diuretika, SSRI, ACE inhibitory<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Riziko aditivn\u00ed hyponatr\u00e9mie<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Kontrolujte hladinu sod\u00edku \u010dast\u011bji.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Verapamil, diltiazem<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Sni\u017ete hladiny MHD oxkarbazepinu (m\u00edrn\u011b)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Obvykle klinicky nev\u00fdznamn\u00e9.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Alkohol<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Aditivn\u00ed CNS deprese a ataxie<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">B\u011bhem u\u017e\u00edv\u00e1n\u00ed Lonaxu se zcela vyhn\u011bte alkoholu.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Inhibitory MAO<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Teoretick\u00e9 riziko \u2014 struktur\u00e1ln\u011b podobn\u00e9 TCA<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Vyhn\u011bte se kombinaci.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Pokyny k uchov\u00e1v\u00e1n\u00ed<\/h2>\n<ul>\n<li>Skladujte p\u0159i pokojov\u00e9 teplot\u011b, <strong>15\u201330\u00b0C<\/strong>. Chra\u0148te p\u0159ed vlhkost\u00ed.<\/li>\n<li>Tablety uchov\u00e1vejte v p\u016fvodn\u00edm blistru a\u017e do pou\u017eit\u00ed.<\/li>\n<li>Neskladujte v koupeln\u011b.<\/li>\n<li>Uchov\u00e1vejte mimo dosah d\u011bt\u00ed.<\/li>\n<li>Nepou\u017e\u00edvejte po uplynut\u00ed data expirace.<\/li>\n<li>Nepou\u017eit\u00e9 tablety vra\u0165te do l\u00e9k\u00e1rny k odborn\u00e9 likvidaci.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Souvisej\u00edc\u00ed alternativy na MedsBase<\/h2>\n<p>Dal\u0161\u00ed l\u00e9ky skladem pro souvisej\u00edc\u00ed stavy:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/neurological-conditions-and-epilepsy\/\">Prohl\u00e9dn\u011bte si v\u0161echny neurologick\u00e9 a antiepileptick\u00e9 l\u00e9ky<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/anti-migraine\/\">Prohl\u00e9dn\u011bte si l\u00e9ky proti migr\u00e9n\u011b<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/mental-health-and-psychiatric-medications\/\">Proch\u00e1zejte l\u00e9ky na du\u0161evn\u00ed zdrav\u00ed a psychiatrick\u00e9 l\u00e9ky<\/a><\/li>\n<\/ul>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3 class=\"wp-block-heading\">Jak se Lonax li\u0161\u00ed od karbamazepinu?<\/h3>\n<p>Oxkarbazepin je 10-keto analog karbamazepinu navr\u017een\u00fd k odstran\u011bn\u00ed aktivn\u00edho epoxidov\u00e9ho metabolitu zodpov\u011bdn\u00e9ho za mnoho vedlej\u0161\u00edch \u00fa\u010dink\u016f a interakc\u00ed karbamazepinu. <strong>Srovnateln\u00e1 \u00fa\u010dinnost, lep\u0161\u00ed sn\u00e1\u0161enlivost, m\u00e9n\u011b l\u00e9kov\u00fdch interakc\u00ed, jednodu\u0161\u0161\u00ed kinetika<\/strong> (\u017e\u00e1dn\u00e1 autoindukce). Kompromisy: oxkarbazepin zp\u016fsobuje <strong>\u010dast\u011bj\u0161\u00ed hyponatr\u00e9mii<\/strong> (2\u20133 % vs &lt;1 % u karbamazepinu) a existuje ~25\u201330% zk\u0159\u00ed\u017een\u00e1 reaktivita pro ko\u017en\u00ed vyr\u00e1\u017eky. Pro v\u011bt\u0161inu nov\u00fdch za\u010d\u00e1tk\u016f u fok\u00e1ln\u00ed epilepsie je oxkarbazepin pohodln\u011bj\u0161\u00ed volbou.<\/p>\n<h3 class=\"wp-block-heading\">Pro\u010d mi l\u00e9ka\u0159 p\u0159i u\u017e\u00edv\u00e1n\u00ed Lonaxu tak \u010dasto kontroluje hladinu sod\u00edku?<\/h3>\n<p><strong>Hyponatr\u00e9mie je nejv\u00fdrazn\u011bj\u0161\u00edm vedlej\u0161\u00edm \u00fa\u010dinkem oxkarbazepinu.<\/strong> Klinicky v\u00fdznamn\u00e1 hyponatr\u00e9mie (&lt;125 mmol\/l) se vyskytuje p\u0159ibli\u017en\u011b u 2\u20133 % dosp\u011bl\u00fdch, \u010dast\u011bji u star\u0161\u00edch pacient\u016f, pacient\u016f u\u017e\u00edvaj\u00edc\u00edch diuretika a pacient\u016f se srde\u010dn\u00edm selh\u00e1n\u00edm. P\u0159\u00edznaky se pohybuj\u00ed od m\u00edrn\u00e9 bolesti hlavy a nevolnosti a\u017e po zmatenost, p\u00e1dy a z\u00e1chvaty. Standardn\u00ed prax\u00ed je \u010dtvrtletn\u00ed m\u011b\u0159en\u00ed s\u00e9rov\u00e9ho sod\u00edku; m\u011bs\u00ed\u010dn\u00ed v p\u0159\u00edpad\u011b zah\u00e1jen\u00ed diuretick\u00e9 l\u00e9\u010dby nebo p\u0159edchoz\u00ed hyponatr\u00e9mie.<\/p>\n<h3 class=\"wp-block-heading\">Mohu u\u017e\u00edvat Lonax, pokud jsem m\u011bl\/a vyr\u00e1\u017eku p\u0159i u\u017e\u00edv\u00e1n\u00ed karbamazepinu?<\/h3>\n<p><strong>Je nutn\u00e1 opatrnost.<\/strong> P\u0159ibli\u017en\u011b <strong>25\u201330 % pacient\u016f, kte\u0159\u00ed m\u011bli vyr\u00e1\u017eku po karbamazepinu, bude m\u00edt vyr\u00e1\u017eku tak\u00e9 po oxkarbazepinu.<\/strong>. Pokud byla va\u0161e p\u0159edchoz\u00ed reakce m\u00edrn\u00e1 benign\u00ed vyr\u00e1\u017eka, kter\u00e1 po vysazen\u00ed karbamazepinu vymizela, lze oxkarbazepin vyzkou\u0161et s pe\u010dliv\u00fdm monitorov\u00e1n\u00edm (nebo p\u0159edl\u00e9\u010debn\u00fdm testov\u00e1n\u00edm HLA-B*1502 u rizikov\u00fdch populac\u00ed). Pokud byla p\u0159edchoz\u00ed reakce Stevens-Johnson\u016fv syndrom, toxick\u00e1 epiderm\u00e1ln\u00ed nekrol\u00fdza (TEN), DRESS nebo anafylaxe, je oxkarbazepin kontraindikov\u00e1n.<\/p>\n<h3 class=\"wp-block-heading\">Pro\u010d n\u011bkter\u00e9 etnick\u00e9 skupiny pot\u0159ebuj\u00ed p\u0159ed nasazen\u00edm Lonaxu genetick\u00fd test?<\/h3>\n<p>Pacienti <strong>hansk\u00e9ho \u010d\u00ednsk\u00e9ho, thajsk\u00e9ho nebo indon\u00e9sk\u00e9ho p\u016fvodu<\/strong> kte\u0159\u00ed nesou <strong>alel HLA-B*1502<\/strong> maj\u00ed v\u00fdrazn\u011b zv\u00fd\u0161en\u00e9 riziko Stevens-Johnsonova syndromu a toxick\u00e9 epiderm\u00e1ln\u00ed nekrol\u00fdzy p\u0159i u\u017e\u00edv\u00e1n\u00ed oxkarbazepinu a karbamazepinu. FDA doporu\u010duje p\u0159ed l\u00e9\u010dbou testov\u00e1n\u00ed na HLA-B*1502 u t\u011bchto populac\u00ed. Test se prov\u00e1d\u00ed jednor\u00e1zov\u011b z krve nebo st\u011bru z \u00fastn\u00ed sliznice; pacienti s pozitivn\u00edm HLA-B*1502 by obecn\u011b m\u011bli oxkarbazepinu a karbamazepinu vyh\u00fdbat.<\/p>\n<h3 class=\"wp-block-heading\">M\u016f\u017ee Lonax ovlivnit \u00fa\u010dinnost antikoncep\u010dn\u00edch pilulek?<\/h3>\n<p><strong>P\u0159i d\u00e1vk\u00e1ch nad 1 200 mg\/den, ano.<\/strong> Oxkarbazepin m\u00edrn\u011b indukuje CYP3A4 a sni\u017euje hladiny ethinylestradiolu a levonorgestrelu p\u0159ibli\u017en\u011b o 50 % p\u0159i vy\u0161\u0161\u00edch d\u00e1vk\u00e1ch. P\u0159i d\u00e1vk\u00e1ch pod 1 200 mg\/den je \u00fa\u010dinek mal\u00fd. Pokud u\u017e\u00edv\u00e1te v\u00edce ne\u017e 1 200 mg\/den, pou\u017eijte pilulku obsahuj\u00edc\u00ed alespo\u0148 50 \u00b5g ethinylestradiolu, p\u0159ejd\u011bte na neestrogenn\u00ed metodu (depot nebo nitrod\u011blo\u017en\u00ed t\u011bl\u00edsko) nebo p\u0159idejte bari\u00e9rovou ochranu. Progestogenn\u00ed pilulky jsou na oxkarbazepinu m\u00e9n\u011b spolehliv\u00e9.<\/p>\n<h3 class=\"wp-block-heading\">Je Lonax bezpe\u010dn\u00fd v t\u011bhotenstv\u00ed?<\/h3>\n<p>Oxkarbazepin je FDA t\u011bhotensk\u00e1 kategorie C. Data z registr\u016f nazna\u010duj\u00ed m\u00edrn\u00e9 zv\u00fd\u0161en\u00ed v\u00fdskytu velk\u00fdch vrozen\u00fdch vad oproti z\u00e1kladn\u00ed populaci, m\u00e9n\u011b ne\u017e valpro\u00e1t nebo topiram\u00e1t. Stejn\u011b jako jin\u00e1 antikonvulziva sni\u017euje hladinu fol\u00e1tu \u2014 <strong>doporu\u010duje se 5 mg\/den kyseliny listov\u00e9 p\u0159ed po\u010det\u00edm a b\u011bhem prvn\u00edho trimestru<\/strong>. Je nezbytn\u00fd odborn\u00fd dohled a d\u00e1vka m\u016f\u017ee pot\u0159ebovat \u00fapravu, proto\u017ee clearance se v t\u011bhotenstv\u00ed zvy\u0161uje. Rozhodnut\u00ed pokra\u010dovat v l\u00e9\u010db\u011b je rovnov\u00e1hou mezi rizikem z\u00e1chvat\u016f pro matku a rizikem expozice plodu; nep\u0159eru\u0161ujte l\u00e9\u010dbu n\u00e1hle bez odborn\u00e9ho poradenstv\u00ed.<\/p>\n<h3 class=\"wp-block-heading\">Zp\u016fsobuje Lonax ospalost nebo ovliv\u0148uje schopnost \u0159\u00eddit?<\/h3>\n<p>Ospalost, z\u00e1vrat\u011b, dvojit\u00e9 vid\u011bn\u00ed a ataxie jsou b\u011b\u017en\u00e9 b\u011bhem prvn\u00edch 2\u20133 t\u00fddn\u016f titrace. V\u011bt\u0161ina pacient\u016f se p\u0159izp\u016fsob\u00ed b\u011bhem 4\u20136 t\u00fddn\u016f. <strong>Vyhn\u011bte se \u0159\u00edzen\u00ed b\u011bhem titrace a po zv\u00fd\u0161en\u00ed d\u00e1vky<\/strong> dokud nezjist\u00edte, jak na l\u00e9k reagujete. Pokud dvojit\u00e9 vid\u011bn\u00ed p\u0159etrv\u00e1v\u00e1 p\u0159i udr\u017eovac\u00ed d\u00e1vce, sn\u00ed\u017een\u00ed d\u00e1vky obvykle probl\u00e9m vy\u0159e\u0161\u00ed.<\/p>\n<h3 class=\"wp-block-heading\">M\u016f\u017ee Lonax l\u00e9\u010dit trigemin\u00e1ln\u00ed neuralgii?<\/h3>\n<p><strong>Ano \u2014 mimo schv\u00e1len\u00e9 indikace, ale dob\u0159e zaveden\u00e9.<\/strong> Trigemin\u00e1ln\u00ed neuralgie reaguje na blok\u00e1tory sod\u00edkov\u00fdch kan\u00e1l\u016f; karbamazepin je schv\u00e1lenou l\u00e9\u010dbou prvn\u00ed volby, ale oxkarbazepin m\u00e1 srovnatelnou \u00fa\u010dinnost s lep\u0161\u00ed sn\u00e1\u0161enlivost\u00ed a je \u0161iroce pou\u017e\u00edv\u00e1n jako alternativa, kdy\u017e je karbamazepin \u0161patn\u011b tolerov\u00e1n. Typick\u00e9 d\u00e1vky jsou 600\u20131 800 mg\/den ve 2 rozd\u011blen\u00fdch d\u00e1vk\u00e1ch.<\/p>\n<h3 class=\"wp-block-heading\">Mohu p\u00edt alkohol p\u0159i u\u017e\u00edv\u00e1n\u00ed Lonaxu?<\/h3>\n<p>Lehk\u00e1, p\u0159\u00edle\u017eitostn\u00e1 konzumace alkoholu je obvykle tolerov\u00e1na. Nadm\u011brn\u00e9 pit\u00ed zvy\u0161uje depresi CNS, sni\u017euje pr\u00e1h pro z\u00e1chvaty a zhor\u0161uje hyponatr\u00e9mii podporou diur\u00e9zy. \u00dapln\u011b se vyhn\u011bte n\u00e1razov\u00e9mu pit\u00ed.<\/p>\n<h3 class=\"wp-block-heading\">Jak bezpe\u010dn\u011b vysadit Lonax?<\/h3>\n<p>Sni\u017eujte d\u00e1vku p\u0159ibli\u017en\u011b o <strong>20\u201325 % t\u00fddn\u011b<\/strong> pod dohledem neurologa \u2014 rychlej\u0161\u00ed vysazov\u00e1n\u00ed zvy\u0161uje riziko rebound z\u00e1chvat\u016f a status epilepticus. N\u00e1hl\u00e9 vysazen\u00ed je vyhrazeno pouze pro z\u00e1va\u017en\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky (t\u011b\u017ek\u00e1 vyr\u00e1\u017eka, DRESS, SJS, t\u011b\u017ek\u00e1 hyponatr\u00e9mie).<\/p>\n<h3 class=\"wp-block-heading\">Kde se Lonax vyr\u00e1b\u00ed?<\/h3>\n<p>Lonax je dod\u00e1v\u00e1n spole\u010dnost\u00ed <strong>v\u00fdrobce certifikovan\u00e9ho WHO-GMP<\/strong> a je bioekvivalentn\u00ed s origin\u00e1ln\u00edm oxkarbazepinem (Trileptal\u00ae, Novartis). Certifik\u00e1ty anal\u00fdzy \u0161ar\u017e\u00ed jsou k dispozici na vy\u017e\u00e1d\u00e1n\u00ed.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Souvisej\u00edc\u00ed alternativy<\/h3>\n<p>Dal\u0161\u00ed produkty v <strong>Chronick\u00e1 onemocn\u011bn\u00ed<\/strong> kter\u00e9 z\u00e1kazn\u00edci tak\u00e9 prohl\u00ed\u017eej\u00ed:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/avonza\/\">Avonza<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/amaryl\/\">Amaryl<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/topme-xl\/\">Topme XL<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/combutol\/\">Combutol<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/nimodip-nimodipine\/\">Nimodip (Nimodipin)<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Kontrola z\u00e1chvat\u016f<br \/>\n\u2705 Stabilizace n\u00e1lady<br \/>\n\u2705 Sn\u00ed\u017een\u00ed neuropatick\u00e9 bolesti<br \/>\n\u2705 Jednor\u00e1zov\u00e1 denn\u00ed d\u00e1vka<br \/>\n\u2705 M\u00e9n\u011b vedlej\u0161\u00edch \u00fa\u010dink\u016f<\/p>\n<p>Lonax obsahuje oxkarbazepin.<\/p>","protected":false},"featured_media":59944,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3468],"product_tag":[4773,4535],"class_list":{"0":"post-59943","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-neurological-conditions-and-epilepsy","9":"product_tag-lonax","10":"product_tag-oxcarbazepine","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/59943","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=59943"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/59944"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=59943"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=59943"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=59943"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=59943"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}